Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company oncgnostics GmbH
DescriptionDetects methlyation of specific biomarkers present in cervical cancer or its precursors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetect cervical precancerous lesions and cancer
Regulatory Designation
PartnerMDxHealth S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today